Summary: Antiviral treatment of hepatitis C virus

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 77-82

  Dusheiko, G M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INDOMETACIN; RIBAVIRIN; THYMOSIN; URSODEOXYCHOLIC ACID; VIRUS RNA; ZIDOVUDINE;

ACUTE HEPATITIS; CHRONIC HEPATITIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; MYALGIA; PRIORITY JOURNAL; RASH; TASTE DISORDER; XEROSTOMIA;

EID: 0029868828     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00923-X     Document Type: Conference Paper

References (30)

1. Chan, S.-W., Simmonds, P., McOmish, F., Yap, P.-L., Mitchell, R., Dow, B. and Follett, E. (1991) Serological responses to infection with three different types of hepatitis C virus. Lancet 338, 1391
2. Chayama, K., Saitoh, S., Arase, Y., Ikeda, K., Matsumoto, T., Sakai, Y., Kobayashi, M., Unakami, M., Morinaga, T. and Kumada, H. (1991) Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 13, 1040-1043.
3. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghton, M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
4. Choo, Q.L., Weiner, A.J., Overby, L.R., Kuo, G., Houghton, M. and Bradley, D.W. (1990) Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 46, 423-441.
5. Czaja, A.J., Taswell, H.F., Rakela, J. and Schimek, C.M. (1991) Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis (see comments). Mayo Clin. Proc. 66, 572-582.
6. Davis, G.L. (1991) Hepatitis C virus antibody in patients with chronic autoimmune hepatitis: pitfalls in diagnosis and implications for treatment (editorial; comment). Mayo Clin. Proc. 66, 647-650.
7. Davis, G.L., Balart, L.A., Schiff, E.R., Lindsay, K., Bodenheimer, H.C.J., Perrillo, R.P., Carey, W., Jacobson, I.M., Payne, J., Dienstag, J.L. et al. (1989) Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N. Engl. J. Med. 321, 1501-1506.
8. Dianzani, F. (1993) Biological basis for the clinical use of interferon. Gut 34 (Suppl.), S74-S76.
9. Di-Bisceglie, A.M., Martin, P., Kassianides, C., Lisker-Melman, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S.M. and Hoofnagle, J.H. (1989) Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 321, 1506-1510.
10. Feray, C., Samuel, D., Thiers, V., Gigou, M., Pichon, F., Bismuth, A., Reynes, M., Maisonneuve, P., Bismuth, H. and Bréchet, C. (1992) Reinfection of liver graft by hepatitis C virus after liver transplantation. J. Clin. Invest. 89, 1361-1365.
11. Fernandez, H., Banks, G. and Smith, R. (1986) Ribavirin: a clinical overview. Eur. J. Epidemiol. 2, 1-14.
12. Ferrell, L.D., Wright, T.L., Roberts, J., Ascher, N. and Lake, J. (1992) Hepatitis C viral infection in liver transplant recipients. Hepatology 16, 865-876.
13. Iino, S., Hino, K., Kuroki, T., Suzuki, H. and Yamamoto, S. (1993) Treatment of chronic hepatitis C with high-dose interferon α-2b: A multicenter study. Dig. Dis. Sci. 38, 612-618.
14. Krawczynski, K., Beach, M.J., Bradley, D.W., Kuo, G., Di Bisceglie, A.M., Houghton, M., Reyes, G.R., Kim, J.P., Choo, Q.-L. and Alter, M.J. (1992) Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identification. Gastroenterology 103, 622-629.
15. Kuo, G., Choo, Q.L., Alter, H.J., Gitnick, G.L., Redeker, A.G., Purcell, R.H., Miyamura, T., Dienstag, J.L., Alter, M.J., Stevens, C.E. et al. (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364.
16. Lenzi, M., Johnson, P.J., McFarlane, I.G., Ballardini, G., Smith, H.M., McFarlane, B.M., Bridger, C., Vergani, D., Bianchi, F.B. and Williams, R. (1991) Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 338, 277-280.
17. McOmish, F., Chan, S.-W., Dow, B.C., Gillon, J., Frame, W.D., Crawford, R.J., Yap, P.-L., Follett, E.A.C. and Simmonds, P. (1993) Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33, 7-13.
18. Mishiro, S., Hoshi, Y., Takeda, K., Yoshikawa, A., Gotanda, T., Takahashi, K., Akahane, Y., Yoshizawa, H., Okamoto, H., Tsuda, F., et al. (1990) Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 336, 1400-1403.
19. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y. and Mayumi, M. (1992a) Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73, 673-679.
20. Okamoto, H., Kurai, K., Okada, S.-I., Yamamoto, K., Lizuka, H., Tanaka, T., Fukuda, S., Tsuda, F. and Mishiro, S. (1992b) Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 188, 331-341.
21. Omata, M., Yokosuka, O., Takano, S., Kato, N., Hosoda, K., Imazeki, F., Tada, M., Ito, Y. and Ohto, M. (1991) Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338, 914-915.
22. Onji, M., Kikuchi, T., Michitaka, K., Saito, I., Miyamura, T. and Ohta, Y. (1991) Detection of hepatitis C virus antibody in patients with autoimmune hepatitis and other chronic liver diseases. Gastroenterol. Jpn. 26, 182-186.
23. Poterucha, J.J., Rakela, J., Lumeng, L., Lee, C.-H., Taswell, H.F. and Wiesner, R.H. (1992) Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction. Hepatology 15, 42-45.
24. Rassam, S. and Dusheiko, G. (19920 Ribavirin treatment of chronic hepatitis C: a phase I study. Submitted.
25. Read, A.E., Donegan, E., Lake, J., Ferrell, L., Galbraith, C., Kuramoto, I.K., Zeldis, J.B., Ascher, N.L., Roberts, J. and Wright, T.L. (1991) Hepatitis C in liver transplant recipients. Transplant Proc. 23, 1504-1505.
26. Reichard, O., Andersson, J., Schvarcz, R. and Weiland, O. (1991) Ribavirin treatment for chronic hepatitis C. Lancet 337, 1058-1061.
27. Varagona, G., Brown, D., Kibbler, H., Scheuer, P., Ashrafzadeh, P., Sherlock, S., McIntyre, N. and Dusheiko, G. (1992) Response, relapse and retreatment rates and viraemia in chronic hepatitis C treated with α2b interferon. A phase III study. Eur. J. Gastroent. Hepatol. 4, 707-712.
28. Wright, T.L., Donegan, E., Hsu, H.H., Ferrell, L., Lake, J.R., Kim, M., Combs, C., Fennessy, S., Roberts, J.P., Ascher, N.L. and Greenberg, H.B. (1992) Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103, 317-322.
29. Yamada, G., Takahashi, M., Tsuji, T., Yoshizawa, H. and Okamoto, H. (1992) Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C. Dig. Dis. Sci. 37, 1926-1927.
30. Zignego, A.L., Samuel, D., Gigou, M., Feray, C., Arulnaden, J.-L., Monti, M., Gentilini, P., Reynes, M., Benhamou, J.P., Brechet, C. and Bismuth, H. (1993) Patterns of hepatitis delta reinfection after liver transplantation and their evolution during a long term follow-up. Prog. Clin. Biol. Res. 382, 409-417.